Literature DB >> 4984207

Incidence of mucoid Pseudomonas aeruginosa from clinical sources.

R G Doggett.   

Abstract

The high frequency of pulmonary infection by mucoid strains of Pseudomonas aeruginosa in patients with cystic fibrosis can be interpreted to represent an apparent mutation resulting from environmental factors within the host.

Entities:  

Mesh:

Year:  1969        PMID: 4984207      PMCID: PMC378118          DOI: 10.1128/am.18.5.936-937.1969

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  3 in total

1.  ENCAPSULATED PSEUDOMONAS AERUGINOSA (PSEUDOMONAS AERUGINOSA MUCOSUS) STRAINS.

Authors:  E T CETIN; K TOERECI; O ANG
Journal:  J Bacteriol       Date:  1965-05       Impact factor: 3.490

2.  Increasing incidence of encapsulated Pseudomonas aeruginosa strains.

Authors:  H R Elston; K C Hoffman
Journal:  Am J Clin Pathol       Date:  1967-11       Impact factor: 2.493

3.  COMPARISON OF SOME PROPERTIES OF PSEUDOMONAS AERUGINOSA ISOLATED FROM INFECTIONS IN PERSONS WITH AND WITHOUT CYSTIC FIBROSIS.

Authors:  R G DOGGETT; G M HARRISON; E S WALLIS
Journal:  J Bacteriol       Date:  1964-02       Impact factor: 3.490

  3 in total
  52 in total

Review 1.  Chromosomal genetics of Pseudomonas.

Authors:  B W Holloway; V Krishnapillai; A F Morgan
Journal:  Microbiol Rev       Date:  1979-03

2.  Characterization of temporal protein production in Pseudomonas aeruginosa biofilms.

Authors:  Christopher J Southey-Pillig; David G Davies; Karin Sauer
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

Review 3.  Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.

Authors:  Deepak Balasubramanian; Hansi Kumari; Kalai Mathee
Journal:  Pathog Dis       Date:  2015-02-26       Impact factor: 3.166

4.  Scnn1b-Transgenic BALB/c Mice as a Model of Pseudomonas aeruginosa Infections of the Cystic Fibrosis Lung.

Authors:  Kristen J Brao; Brendan P Wille; Joshua Lieberman; Robert K Ernst; Mark E Shirtliff; Janette M Harro
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

5.  Inability of purified Pseudomonas aeruginosa exopolysaccharide to bind selected antibiotics.

Authors:  C S Tannenbaum; A T Hastie; M L Higgins; F Kueppers; G Weinbaum
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

6.  Cif is negatively regulated by the TetR family repressor CifR.

Authors:  Daniel P MacEachran; Bruce A Stanton; George A O'Toole
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

7.  Toxic activity against alveolar macrophages of products of Pseudomonas aeruginosa isolated from respiratory and non-respiratory sites.

Authors:  A H Al-Dujaili
Journal:  J Hyg (Lond)       Date:  1976-10

8.  Serotyping of Pseudomonas aeruginosa isolates from patients with cystic fibrosis of the pancreas.

Authors:  C H Zierdt; R L Williams
Journal:  J Clin Microbiol       Date:  1975-06       Impact factor: 5.948

9.  Pseudomonas aeruginosa AlgR controls cyanide production in an AlgZ-dependent manner.

Authors:  William L Cody; Christopher L Pritchett; Adriana K Jones; Alexander J Carterson; Debra Jackson; Anders Frisk; Matthew C Wolfgang; Michael J Schurr
Journal:  J Bacteriol       Date:  2009-03-06       Impact factor: 3.490

Review 10.  Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.

Authors:  T B May; D Shinabarger; R Maharaj; J Kato; L Chu; J D DeVault; S Roychoudhury; N A Zielinski; A Berry; R K Rothmel
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.